Differentiating Neuromyelitis Optica–Related and Multiple Sclerosis–Related Acute Optic Neuritis Using Conventional Magnetic Resonance Imaging Combined With Readout-Segmented Echo-Planar Diffusion-Weighted Imaging

Purpose In clinical practice, acute optic neuritis (ON) associated with the development of neuromyelitis optica (NMO) after the first attack is often indistinguishable from that associated with multiple sclerosis (MS). We aimed to determine the optimal combination of features derived from conventional magnetic resonance imaging (MRI) and diffusion-weighted imaging using readout-segmented echo-planar imaging (RESOLVE-DWI) for the differentiation of these conditions. Materials and Methods Orbital conventional MRI and RESOLVE-DWI were performed using a 3.0-T scanner on 54 patients with acute ON (26 NMO-related and 28 MS-related). The features detected by conventional MRI (including laterality, the enhancement pattern, and the extent and position of involvement) and the apparent diffusion coefficient (ADC) measurements were retrospectively compared between the NMO-related and MS-related groups. A multivariate logistic regression analysis was used to identify the most significant variables, and receiver operating characteristic curve analyses were performed to determine the ability of a combined diagnostic model based on the qualitative and quantitative characteristics identified in this study to differentiate the 2 conditions. Results The multivariate logistic regression analyses indicated that the presence of chiasm involvement and lower ADC values were significantly associated with NMO-related acute ON compared with MS-related acute ON (P = 0.037 and 0.008, respectively). The diagnostic criterion of chiasm involvement or “ADC < 791 × 10−6 mm2/s and chiasm involvement” had the highest specificity (96.9%), and “ADC < 791 × 10−6 mm2/s or chiasm involvement” showed the optimal sensitivity (77.8%) for differentiating NMO-related from MS-related acute ON. Conclusions Conventional MRI RESOLVE-DWI is helpful for differentiating NMO-related acute ON from MS-related acute ON. The combination of the ADC value chiasm involvement appears to be effective for discriminating these 2 types of acute ON.

[1]  M. Mori,et al.  Diffuse and heterogeneous T2-hyperintense lesions in the splenium are characteristic of neuromyelitis optica , 2013, Multiple sclerosis.

[2]  M. Krumbholz,et al.  Interferon-beta increases BAFF levels in multiple sclerosis: implications for B cell autoimmunity. , 2008, Brain : a journal of neurology.

[3]  G. Plant,et al.  Distinguishing Optic Neuritis in Neuromyelitis Optica Spectrum Disease From Multiple Sclerosis: A Novel Magnetic Resonance Imaging Scoring System , 2013, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.

[4]  N. Raz,et al.  Functional MRI as a tool for assessing chiasmal visual defect in a patient with neuromyelitis optica , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[5]  Y. Sha,et al.  Role of coronal high-resolution diffusion-weighted imaging in acute optic neuritis: a comparison with axial orientation , 2017, Neuroradiology.

[6]  C. Tan International consensus diagnostic criteria for neuromyelitis optica spectrum disorders , 2016, Neurology.

[7]  A. Reder,et al.  Homonymous hemimacular thinning: a unique presentation of optic tract injury in neuromyelitis optica. , 2012, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.

[8]  A. McKinney,et al.  Accuracy of routine fat-suppressed FLAIR and diffusion-weighted images in detecting clinically evident acute optic neuritis. , 2013, Acta Radiologica.

[9]  B E Kendall,et al.  The pathophysiology of acute optic neuritis. An association of gadolinium leakage with clinical and electrophysiological deficits. , 1991, Brain : a journal of neurology.

[10]  M. Monteiro,et al.  Comparison of Visual Acuity and Automated Perimetry Findings in Patients With Neuromyelitis Optica or Multiple Sclerosis After Single or Multiple Attacks of Optic Neuritis , 2012, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.

[11]  A. Gentles,et al.  Clinical Application of Readout-Segmented− Echo-Planar Imaging for Diffusion-Weighted Imaging in Pediatric Brain , 2011, American Journal of Neuroradiology.

[12]  R. Zivadinov,et al.  Conventional and Advanced Imaging in Neuromyelitis Optica , 2014, American Journal of Neuroradiology.

[13]  M. Kupersmith,et al.  Contrast-enhanced MRI in acute optic neuritis: relationship to visual performance. , 2002, Brain : a journal of neurology.

[14]  M. Gordon,et al.  Magnetic Resonance Imaging of Optic Neuritis in Patients With Neuromyelitis Optica Versus Multiple Sclerosis , 2012, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.

[15]  J. Pula,et al.  Longitudinally extensive optic neuritis in neuromyelitis optica spectrum disorder , 2014, Journal of the Neurological Sciences.

[16]  G. Barker,et al.  Diffusion-weighted imaging of the spinal cord and optic nerve , 2001, Journal of the Neurological Sciences.

[17]  I. Izbudak,et al.  Longitudinally extensive optic neuritis as an MRI biomarker distinguishes neuromyelitis optica from multiple sclerosis , 2015, Journal of the Neurological Sciences.

[18]  Fang Zhang,et al.  Diffusion‐weighted imaging helps differentiate multiple sclerosis and neuromyelitis optica‐related acute optic neuritis , 2017, Journal of magnetic resonance imaging : JMRI.

[19]  Jeffrey A. Cohen,et al.  Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria , 2011, Annals of neurology.

[20]  Y. Lim,et al.  First-ever optic neuritis: distinguishing subsequent neuromyelitis optica from multiple sclerosis , 2014, Neurological Sciences.

[21]  U. Motosugi,et al.  Diffusion-Weighted Imaging in Optic Neuritis , 2013, Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes.

[22]  David H. Miller,et al.  Clinically isolated syndromes , 2012, The Lancet Neurology.

[23]  Masami Tanaka,et al.  Interferon-β1b Treatment in Neuromyelitis Optica , 2009, European Neurology.

[24]  Robin M Heidemann,et al.  High resolution diffusion‐weighted imaging using readout‐segmented echo‐planar imaging, parallel imaging and a two‐dimensional navigator‐based reacquisition , 2009, Magnetic resonance in medicine.

[25]  A. Verkman,et al.  Optic neuritis in neuromyelitis optica , 2013, Progress in Retinal and Eye Research.

[26]  B. Weinshenker,et al.  The spectrum of neuromyelitis optica , 2007, The Lancet Neurology.

[27]  Craig K. Jones,et al.  Applications of stimulated echo correction to multicomponent T2 analysis , 2012, Magnetic resonance in medicine.

[28]  J. Sedlacik,et al.  Noise robust spatially regularized myelin water fraction mapping with the intrinsic B1‐error correction based on the linearized version of the extended phase graph model , 2016, Journal of magnetic resonance imaging : JMRI.

[29]  S. Oh,et al.  Initial Pattern of Optic Nerve Enhancement in Korean Patients with Unilateral Optic Neuritis , 2017, Korean journal of ophthalmology : KJO.

[30]  Ichiro Nakashima,et al.  A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis , 2004, The Lancet.

[31]  J. Horton,et al.  Reduced apparent diffusion coefficient in neuromyelitis optica-associated optic neuropathy. , 2015, Journal of neuro-ophthalmology.

[32]  Jacqueline A Palace,et al.  Interferon Beta treatment in neuromyelitis optica: increase in relapses and aquaporin 4 antibody titers. , 2010, Archives of neurology.

[33]  David H. Miller,et al.  Optic neuritis , 2014, The Lancet Neurology.

[34]  D. Kerr,et al.  Differential expression of aquaporin-4 isoforms localizes with neuromyelitis optica disease activity , 2010, Journal of Neuroimmunology.

[35]  R. Sergott “Cloud-like Enhancement” Is a Magnetic Resonance Imaging Abnormality Specific to Neuromyelitis Optica , 2010 .